 | • レポートコード：MRC2312MG14419 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥721,500 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の創薬スクリーニングサービス市場規模と予測を収録しています。・世界の創薬スクリーニングサービス市場：売上、2018年-2023年、2024年-2029年 ・世界の創薬スクリーニングサービス市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の創薬スクリーニングサービス市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「表現型スクリーニング」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 創薬スクリーニングサービスのグローバル主要企業は、Charles River Laboratories、 Evotec、 TargetMol、 Abeomics、 DefiniGEN、 Multispan、 MIMETAS、 Melior Discovery、 Thermo Fisher、 Eurofins Discovery、 Horizon Discovery、 Crown Bioscience、 Pharmaron、 Beijing Abace Biotechnology、 Viva Biotech Holdings、 HD Biosciences、 SAFE Pharmaceutical Technology、 Shanghai Medicilonなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、創薬スクリーニングサービスのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の創薬スクリーニングサービス市場：タイプ別、2018年-2023年、2024年-2029年 世界の創薬スクリーニングサービス市場：タイプ別市場シェア、2022年 ・表現型スクリーニング、ターゲットスクリーニング 世界の創薬スクリーニングサービス市場：用途別、2018年-2023年、2024年-2029年 世界の創薬スクリーニングサービス市場：用途別市場シェア、2022年 ・製薬会社、研究機関、その他 世界の創薬スクリーニングサービス市場：地域・国別、2018年-2023年、2024年-2029年 世界の創薬スクリーニングサービス市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における創薬スクリーニングサービスのグローバル売上、2018年-2023年 ・主要企業における創薬スクリーニングサービスのグローバル売上シェア、2022年 ・主要企業における創薬スクリーニングサービスのグローバル販売量、2018年-2023年 ・主要企業における創薬スクリーニングサービスのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Charles River Laboratories、 Evotec、 TargetMol、 Abeomics、 DefiniGEN、 Multispan、 MIMETAS、 Melior Discovery、 Thermo Fisher、 Eurofins Discovery、 Horizon Discovery、 Crown Bioscience、 Pharmaron、 Beijing Abace Biotechnology、 Viva Biotech Holdings、 HD Biosciences、 SAFE Pharmaceutical Technology、 Shanghai Medicilon ************************************************************* ・調査・分析レポートの概要 創薬スクリーニングサービス市場の定義 市場セグメント 世界の創薬スクリーニングサービス市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の創薬スクリーニングサービス市場規模 世界の創薬スクリーニングサービス市場規模：2022年 VS 2029年 世界の創薬スクリーニングサービス市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの創薬スクリーニングサービスの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の創薬スクリーニングサービス製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：表現型スクリーニング、ターゲットスクリーニング 創薬スクリーニングサービスのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：製薬会社、研究機関、その他 創薬スクリーニングサービスの用途別グローバル売上・予測 ・地域別市場分析 地域別創薬スクリーニングサービス市場規模 2022年と2029年 地域別創薬スクリーニングサービス売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Charles River Laboratories、 Evotec、 TargetMol、 Abeomics、 DefiniGEN、 Multispan、 MIMETAS、 Melior Discovery、 Thermo Fisher、 Eurofins Discovery、 Horizon Discovery、 Crown Bioscience、 Pharmaron、 Beijing Abace Biotechnology、 Viva Biotech Holdings、 HD Biosciences、 SAFE Pharmaceutical Technology、 Shanghai Medicilon ... |
This research report provides a comprehensive analysis of the Drug Discovery Screening Service market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Drug Discovery Screening Service market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Drug Discovery Screening Service, challenges faced by the industry, and potential opportunities for market players.
The global Drug Discovery Screening Service market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Drug Discovery Screening Service market presents opportunities for various stakeholders, including Pharmaceutical Company, Research Institute. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Drug Discovery Screening Service market. Additionally, the growing consumer demand present avenues for market expansion.
The global Drug Discovery Screening Service market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Drug Discovery Screening Service market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Drug Discovery Screening Service market.
Market Overview: The report provides a comprehensive overview of the Drug Discovery Screening Service market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Phenotypic Screening, Target Screening), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Drug Discovery Screening Service market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Drug Discovery Screening Service market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Drug Discovery Screening Service market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Drug Discovery Screening Service market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Drug Discovery Screening Service market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Drug Discovery Screening Service market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Drug Discovery Screening Service, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Drug Discovery Screening Service market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Drug Discovery Screening Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Phenotypic Screening
Target Screening
Market segment by Application
Pharmaceutical Company
Research Institute
Others
Global Drug Discovery Screening Service Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Charles River Laboratories
Evotec
TargetMol
Abeomics
DefiniGEN
Multispan
MIMETAS
Melior Discovery
Thermo Fisher
Eurofins Discovery
Horizon Discovery
Crown Bioscience
Pharmaron
Beijing Abace Biotechnology
Viva Biotech Holdings
HD Biosciences
SAFE Pharmaceutical Technology
Shanghai Medicilon
Outline of Major Chapters:
Chapter 1: Introduces the definition of Drug Discovery Screening Service, market overview.
Chapter 2: Global Drug Discovery Screening Service market size in revenue.
Chapter 3: Detailed analysis of Drug Discovery Screening Service company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drug Discovery Screening Service in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Drug Discovery Screening Service Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drug Discovery Screening Service Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drug Discovery Screening Service Overall Market Size
2.1 Global Drug Discovery Screening Service Market Size: 2022 VS 2029
2.2 Global Drug Discovery Screening Service Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drug Discovery Screening Service Players in Global Market
3.2 Top Global Drug Discovery Screening Service Companies Ranked by Revenue
3.3 Global Drug Discovery Screening Service Revenue by Companies
3.4 Top 3 and Top 5 Drug Discovery Screening Service Companies in Global Market, by Revenue in 2022
3.5 Global Companies Drug Discovery Screening Service Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drug Discovery Screening Service Players in Global Market
3.6.1 List of Global Tier 1 Drug Discovery Screening Service Companies
3.6.2 List of Global Tier 2 and Tier 3 Drug Discovery Screening Service Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Drug Discovery Screening Service Market Size Markets, 2022 & 2029
4.1.2 Phenotypic Screening
4.1.3 Target Screening
4.2 By Type – Global Drug Discovery Screening Service Revenue & Forecasts
4.2.1 By Type – Global Drug Discovery Screening Service Revenue, 2018-2023
4.2.2 By Type – Global Drug Discovery Screening Service Revenue, 2024-2029
4.2.3 By Type – Global Drug Discovery Screening Service Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Drug Discovery Screening Service Market Size, 2022 & 2029
5.1.2 Pharmaceutical Company
5.1.3 Research Institute
5.1.4 Others
5.2 By Application – Global Drug Discovery Screening Service Revenue & Forecasts
5.2.1 By Application – Global Drug Discovery Screening Service Revenue, 2018-2023
5.2.2 By Application – Global Drug Discovery Screening Service Revenue, 2024-2029
5.2.3 By Application – Global Drug Discovery Screening Service Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Drug Discovery Screening Service Market Size, 2022 & 2029
6.2 By Region – Global Drug Discovery Screening Service Revenue & Forecasts
6.2.1 By Region – Global Drug Discovery Screening Service Revenue, 2018-2023
6.2.2 By Region – Global Drug Discovery Screening Service Revenue, 2024-2029
6.2.3 By Region – Global Drug Discovery Screening Service Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Drug Discovery Screening Service Revenue, 2018-2029
6.3.2 US Drug Discovery Screening Service Market Size, 2018-2029
6.3.3 Canada Drug Discovery Screening Service Market Size, 2018-2029
6.3.4 Mexico Drug Discovery Screening Service Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Drug Discovery Screening Service Revenue, 2018-2029
6.4.2 Germany Drug Discovery Screening Service Market Size, 2018-2029
6.4.3 France Drug Discovery Screening Service Market Size, 2018-2029
6.4.4 U.K. Drug Discovery Screening Service Market Size, 2018-2029
6.4.5 Italy Drug Discovery Screening Service Market Size, 2018-2029
6.4.6 Russia Drug Discovery Screening Service Market Size, 2018-2029
6.4.7 Nordic Countries Drug Discovery Screening Service Market Size, 2018-2029
6.4.8 Benelux Drug Discovery Screening Service Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Drug Discovery Screening Service Revenue, 2018-2029
6.5.2 China Drug Discovery Screening Service Market Size, 2018-2029
6.5.3 Japan Drug Discovery Screening Service Market Size, 2018-2029
6.5.4 South Korea Drug Discovery Screening Service Market Size, 2018-2029
6.5.5 Southeast Asia Drug Discovery Screening Service Market Size, 2018-2029
6.5.6 India Drug Discovery Screening Service Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Drug Discovery Screening Service Revenue, 2018-2029
6.6.2 Brazil Drug Discovery Screening Service Market Size, 2018-2029
6.6.3 Argentina Drug Discovery Screening Service Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Drug Discovery Screening Service Revenue, 2018-2029
6.7.2 Turkey Drug Discovery Screening Service Market Size, 2018-2029
6.7.3 Israel Drug Discovery Screening Service Market Size, 2018-2029
6.7.4 Saudi Arabia Drug Discovery Screening Service Market Size, 2018-2029
6.7.5 UAE Drug Discovery Screening Service Market Size, 2018-2029
7 Drug Discovery Screening Service Companies Profiles
7.1 Charles River Laboratories
7.1.1 Charles River Laboratories Company Summary
7.1.2 Charles River Laboratories Business Overview
7.1.3 Charles River Laboratories Drug Discovery Screening Service Major Product Offerings
7.1.4 Charles River Laboratories Drug Discovery Screening Service Revenue in Global Market (2018-2023)
7.1.5 Charles River Laboratories Key News & Latest Developments
7.2 Evotec
7.2.1 Evotec Company Summary
7.2.2 Evotec Business Overview
7.2.3 Evotec Drug Discovery Screening Service Major Product Offerings
7.2.4 Evotec Drug Discovery Screening Service Revenue in Global Market (2018-2023)
7.2.5 Evotec Key News & Latest Developments
7.3 TargetMol
7.3.1 TargetMol Company Summary
7.3.2 TargetMol Business Overview
7.3.3 TargetMol Drug Discovery Screening Service Major Product Offerings
7.3.4 TargetMol Drug Discovery Screening Service Revenue in Global Market (2018-2023)
7.3.5 TargetMol Key News & Latest Developments
7.4 Abeomics
7.4.1 Abeomics Company Summary
7.4.2 Abeomics Business Overview
7.4.3 Abeomics Drug Discovery Screening Service Major Product Offerings
7.4.4 Abeomics Drug Discovery Screening Service Revenue in Global Market (2018-2023)
7.4.5 Abeomics Key News & Latest Developments
7.5 DefiniGEN
7.5.1 DefiniGEN Company Summary
7.5.2 DefiniGEN Business Overview
7.5.3 DefiniGEN Drug Discovery Screening Service Major Product Offerings
7.5.4 DefiniGEN Drug Discovery Screening Service Revenue in Global Market (2018-2023)
7.5.5 DefiniGEN Key News & Latest Developments
7.6 Multispan
7.6.1 Multispan Company Summary
7.6.2 Multispan Business Overview
7.6.3 Multispan Drug Discovery Screening Service Major Product Offerings
7.6.4 Multispan Drug Discovery Screening Service Revenue in Global Market (2018-2023)
7.6.5 Multispan Key News & Latest Developments
7.7 MIMETAS
7.7.1 MIMETAS Company Summary
7.7.2 MIMETAS Business Overview
7.7.3 MIMETAS Drug Discovery Screening Service Major Product Offerings
7.7.4 MIMETAS Drug Discovery Screening Service Revenue in Global Market (2018-2023)
7.7.5 MIMETAS Key News & Latest Developments
7.8 Melior Discovery
7.8.1 Melior Discovery Company Summary
7.8.2 Melior Discovery Business Overview
7.8.3 Melior Discovery Drug Discovery Screening Service Major Product Offerings
7.8.4 Melior Discovery Drug Discovery Screening Service Revenue in Global Market (2018-2023)
7.8.5 Melior Discovery Key News & Latest Developments
7.9 Thermo Fisher
7.9.1 Thermo Fisher Company Summary
7.9.2 Thermo Fisher Business Overview
7.9.3 Thermo Fisher Drug Discovery Screening Service Major Product Offerings
7.9.4 Thermo Fisher Drug Discovery Screening Service Revenue in Global Market (2018-2023)
7.9.5 Thermo Fisher Key News & Latest Developments
7.10 Eurofins Discovery
7.10.1 Eurofins Discovery Company Summary
7.10.2 Eurofins Discovery Business Overview
7.10.3 Eurofins Discovery Drug Discovery Screening Service Major Product Offerings
7.10.4 Eurofins Discovery Drug Discovery Screening Service Revenue in Global Market (2018-2023)
7.10.5 Eurofins Discovery Key News & Latest Developments
7.11 Horizon Discovery
7.11.1 Horizon Discovery Company Summary
7.11.2 Horizon Discovery Business Overview
7.11.3 Horizon Discovery Drug Discovery Screening Service Major Product Offerings
7.11.4 Horizon Discovery Drug Discovery Screening Service Revenue in Global Market (2018-2023)
7.11.5 Horizon Discovery Key News & Latest Developments
7.12 Crown Bioscience
7.12.1 Crown Bioscience Company Summary
7.12.2 Crown Bioscience Business Overview
7.12.3 Crown Bioscience Drug Discovery Screening Service Major Product Offerings
7.12.4 Crown Bioscience Drug Discovery Screening Service Revenue in Global Market (2018-2023)
7.12.5 Crown Bioscience Key News & Latest Developments
7.13 Pharmaron
7.13.1 Pharmaron Company Summary
7.13.2 Pharmaron Business Overview
7.13.3 Pharmaron Drug Discovery Screening Service Major Product Offerings
7.13.4 Pharmaron Drug Discovery Screening Service Revenue in Global Market (2018-2023)
7.13.5 Pharmaron Key News & Latest Developments
7.14 Beijing Abace Biotechnology
7.14.1 Beijing Abace Biotechnology Company Summary
7.14.2 Beijing Abace Biotechnology Business Overview
7.14.3 Beijing Abace Biotechnology Drug Discovery Screening Service Major Product Offerings
7.14.4 Beijing Abace Biotechnology Drug Discovery Screening Service Revenue in Global Market (2018-2023)
7.14.5 Beijing Abace Biotechnology Key News & Latest Developments
7.15 Viva Biotech Holdings
7.15.1 Viva Biotech Holdings Company Summary
7.15.2 Viva Biotech Holdings Business Overview
7.15.3 Viva Biotech Holdings Drug Discovery Screening Service Major Product Offerings
7.15.4 Viva Biotech Holdings Drug Discovery Screening Service Revenue in Global Market (2018-2023)
7.15.5 Viva Biotech Holdings Key News & Latest Developments
7.16 HD Biosciences
7.16.1 HD Biosciences Company Summary
7.16.2 HD Biosciences Business Overview
7.16.3 HD Biosciences Drug Discovery Screening Service Major Product Offerings
7.16.4 HD Biosciences Drug Discovery Screening Service Revenue in Global Market (2018-2023)
7.16.5 HD Biosciences Key News & Latest Developments
7.17 SAFE Pharmaceutical Technology
7.17.1 SAFE Pharmaceutical Technology Company Summary
7.17.2 SAFE Pharmaceutical Technology Business Overview
7.17.3 SAFE Pharmaceutical Technology Drug Discovery Screening Service Major Product Offerings
7.17.4 SAFE Pharmaceutical Technology Drug Discovery Screening Service Revenue in Global Market (2018-2023)
7.17.5 SAFE Pharmaceutical Technology Key News & Latest Developments
7.18 Shanghai Medicilon
7.18.1 Shanghai Medicilon Company Summary
7.18.2 Shanghai Medicilon Business Overview
7.18.3 Shanghai Medicilon Drug Discovery Screening Service Major Product Offerings
7.18.4 Shanghai Medicilon Drug Discovery Screening Service Revenue in Global Market (2018-2023)
7.18.5 Shanghai Medicilon Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer